{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-102104","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2025-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.518086+00:00","generated_at":"2026-05-17T02:24:14.197120+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Theriva Biologics files prospectus supplement for up to $4.02M ATM offering of common stock","bullets":["Up to $4,019,597 of common stock may be sold through A.G.P./Alliance Global Partners as sales agent.","Sales will be at-the-market under Rule 415(a)(4); agent receives up to 3% commission.","Shares offered under existing S-3 shelf (File No. 333-279077) effective September 25, 2024.","No minimum sales obligation; company retains discretion over timing and amount.","Legal opinion on share validity from Parsons Behle & Latimer filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-102104","json":"https://secwatch.observer/filing/0001104659-25-102104.json","markdown":"https://secwatch.observer/filing/0001104659-25-102104.md","text":"https://secwatch.observer/filing/0001104659-25-102104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465925102104/0001104659-25-102104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465925102104/tm2529425d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:24:14.197120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}